You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 11.07 KDa. Observed: 18-22 KDa, reducing conditions
Human
Glu31-Phe124
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.2 KDa. Observed: 37-68 KDa, reducing conditions
Human
Arg20-Pro283
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.2 KDa. Observed: 24-36 KDa, reducing conditions
Human
Val24-Ala243
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 53.27 KDa. Observed: 83 KDa, reducing conditions
Human
Gln22-Ser490
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 85% as determined by SEC-HPLC.(QC verified)
Predicted: 23.27 KDa. Observed: 25-30 KDa, reducing conditions
Human
Phe32-Arg227
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.8 KDa. Observed: 18&37 KDa, reducing conditions
Human
Gly21-Glu147
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 7.73 KDa. Observed: 10-13 KDa, reducing conditions
Human
Gly27-Cys86
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.46 KDa. Observed: 45 KDa, reducing conditions
Human
Ala21-Phe375
C-6His
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.89 KDa. Observed: 57-87 KDa, reducing conditions
Human
Arg206-Ala630
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 53.9 KDa. Observed: 102 KDa, reducing conditions
Human
Asn23-Ala500
C-6His
10 μg, 50 μg, 500 μg, 1 mg
